CanSino Biologics rolls out inhaled vaccine Convidecia Air in Shanghai

CanSino Biologics has announced that its recombinant COVID-19 vaccine (Adenovirus Type 5 Vector) for inhalation (Convide...

November 1, 2022 | Tuesday | News
Hong Kong develops endoscope-assisted micro-robot to eradicate biofilms in ear tubes

Biofilm builds up in the ear tube over time and contributes to otorrhea, or drainage of fluid from the ear, and debris d...

October 28, 2022 | Friday | News
Chinese startup ImmVira completes series C+ funding

China-based startup ImmVira has announced its successful signing of Series-C+ financing transaction documents with the f...

October 27, 2022 | Thursday | News
JW Therapeutics accelerates R&D of T cell-based immunotherapies in China

JW Therapeutics and 2seventy bio have announced a strategic alliance to establish a translational and clinical cell ther...

October 27, 2022 | Thursday | News
WuXi Biologics launches new manufacturing facility in China

WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has successfully...

October 26, 2022 | Wednesday | News
Wuhan Synthetic Biology Innovation Center set to open in China

The investment project of the CABIO R&D Centre officially commenced on 19 October in Wuhan Optical Valley. Upon the ...

October 21, 2022 | Friday | News
Gene delivery startup VectorBuilder secures CNY410 M in Series C round

VectorBuilder Biotechnology (Guangzhou) Co., a top gene delivery startup, recently announced the completion of its Serie...

October 20, 2022 | Thursday | News
China approves Ascendas microfluidics technology

Ascendas Genomics has received approval from the National Medical Products Administration (NMPA) of China for use of the...

October 15, 2022 | Saturday | News
Immuno Cure secures HK$8 M funding support for HIV vaccine clinical trial

Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccin...

October 18, 2022 | Tuesday | News
Chinese startup Jacobio Pharma partners with Merck for cancer clinical trial

China-based startup Jacobio has entered into a clinical trial collaboration agreement with Merck on clinical study of co...

October 14, 2022 | Friday | News
Hong Kong identifies new therapeutic key to end cancer pain

A new study conducted by The Chinese University of Hong Kong’s (CUHK) Faculty of Medicine (CU Medicine) has discov...

October 13, 2022 | Thursday | News
WuXi Biologics and Toregem BioPharma partner to develop tooth regeneration drug

WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) in China, and Tor...

October 12, 2022 | Wednesday | News
Immune-Onc Therapeutics enters into clinical collaboration with BeiGene in China

US-based startup Immune-Onc Therapeutics, Inc. has entered into a clinical trial collaboration and supply agreement with...

October 11, 2022 | Tuesday | News
Hong Kong deploys intelligent interactive robots for older adults and caregivers

The Hong Kong Polytechnic University (PolyU) has announced the signing of a Memorandum of Understanding (MoU) with NEC H...

October 10, 2022 | Monday | News
Hong Kong develops novel RNA nanoparticle for atherosclerosis treatment

A team of researchers at The Chinese University of Hong Kong (CUHK) has developed a novel RNA nanoparticle to offer a po...

October 6, 2022 | Thursday | News
CUHK Professor Dennis Lo receives America's top biomedical science prize

Professor Dennis Lo Yuk Ming from The Chinese University of Hong Kong’s (CUHK) Faculty of Medicine (CU Medicine) h...

October 4, 2022 | Tuesday | News
HKBU partners with ASTRI to explore cutting-edge technologies in pharma & healthcare

Hong Kong Baptist University (HKBU) and the Hong Kong Applied Science and Technology Research Institute (ASTRI) have sig...

October 4, 2022 | Tuesday | News
China's Concord Medical announces changes in management

China-based Concord Medical Services Holdings has announced changes in its management. Yaw Kong Yap has stepped down fr...

October 1, 2022 | Saturday | News
Why Life Sciences sector is Soaring in China

The Life Sciences market in China is expected to continue to develop, becoming one of the most diverse and expansive sec...

October 3, 2022 | Monday | Opinion
"Our drug is now an important treatment for HIV patients in China"

How do you describe Frontier’s relentless efforts in antiviral therapeutics? How have the market trends and pros...

October 3, 2022 | Monday | Opinion
China-based startup NeuShen Therapeutics raises $20 M

China's NeuShen Therapeutics has announced the closure of ~$20 million Series pre-A financing led by LAPAM, a China base...

September 30, 2022 | Friday | News
Simcere, Almirall ink $492 M deal for treating autoimmune diseases

Simcere Pharmaceutical Group, an innovation and R&D-driven pharmaceutical company, and Almirall S.A, a global biopha...

September 29, 2022 | Thursday | News
Hong Kong develops integrated test for children with difficult-to-treat leukaemia

Children with relapsed acute myeloid leukaemia (AML) who develop drug resistance generally lack treatment options and ar...

September 29, 2022 | Thursday | News
WuXi STA opens first high potency oral drug product manufacturing facility

WuXi STA, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the ope...

September 28, 2022 | Wednesday | News
Inventiva and Sino Biopharm ink NASH deal for more than $300 M

French firm Inventiva and Chia Tai-Tianqing Pharmaceutical Group Co. (CTTQ), a subsidiary of China-based Sino Biopharm, ...

September 27, 2022 | Tuesday | News